CVE-2026-21923

MEDIUM
2026-01-20 [email protected]
6.5
CVSS 3.1
Share

CVSS Vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
Attack Vector
Network
Attack Complexity
Low
Privileges Required
None
User Interaction
None
Scope
Unchanged
Confidentiality
Low
Integrity
Low
Availability
None

Lifecycle Timeline

2
Analysis Generated
Mar 12, 2026 - 21:54 vuln.today
CVE Published
Jan 20, 2026 - 22:15 nvd
MEDIUM 6.5

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

Analysis

Life Sciences Central Designer versions up to 7.0.1.0 contains a vulnerability that allows attackers to unauthorized update, insert or delete access to some of Oracle Life Sciences Cen (CVSS 6.5).

Sign in for full analysis, threat intelligence, and remediation guidance.

Remediation

Within 30 days: Identify affected systems and apply vendor patches as part of regular patch cycle. Monitor vendor channels for patch availability.

Sign in for detailed remediation steps.

Priority Score

33
Low Medium High Critical
KEV: 0
EPSS: +0.0
CVSS: +32
POC: 0

Share

CVE-2026-21923 vulnerability details – vuln.today

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy